|
LATEST NEWS
Scripps Research Institute Wins $77 Million to Develop AIDS Vaccine Center
Doores, K. J., Huber, M., Le, K. M., Wang, S. K., Doyle-Cooper, C.,
Cooper, A., Pantophlet, R., Wong, C. H., Nemazee, D. and Burton, D. R.
2012 2G12-expressing B cell lines inform HIV carbohydrate vaccine design
strategies. J. Virol. (In Press)
Burton DR,
Ahmed R, Barouch DH, Butera ST, Crotty S, Godzik A, Kaufmann DE,
McElrath MJ, Nussenzweig MC, Pulendran B, Scanlan CN, Schief WR,
Silvestri G, Streeck H, Walker BD, Walker LM, Ward AB, Wilson IA, and Wyatt
R. (2012) A Blueprint for HIV Vaccine Discovery. Cell Host Microbe. 12:396-407.
Poignard P, Moldt B, Maloveste K, Campos N, Olson WC, Rakasz E, Watkins DI, Burton DR. (2012) Protection against high-dose highly pathogenic mucosal SIV challenge at very low serum neutralizing titers of the antibody-like molecule CD4-IgG2. PLoS One. 7:e42209
Burton DR, Poignard P, Stanfield RL, Wilson IA. (2012) Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science. 337:183-6
|
|
 |
